ad

Biopol Chemicals IPO Day 1: Subscription at 0.12x, GMP Flat | Live Updates

Posted by : sachet | Fri Feb 06 2026

Biopol Chemicals IPO Day 1: Subscription at 0.12x, GMP Flat | Live Updates

The Biopol Chemicals IPO GMP is ₹0 as of 6th February 2026. It is a book-building issue IPO of ₹86.09 crores. This is an entirely fresh issue of 0.49 crore shares. The issue will be listed on NSE and SME on its tentative listing date, 11th February 2026. The face value of Biopol Chemicals IPO shares is ₹10 per share, and the IPO price band is ₹74 to ₹78 per share. Retail investors can bid for a minimum of 2 lots of 3,200 shares worth ₹2,49,600. Scroll down to check the Biopol Chemicals IPO GMP and subscription details.

Biopol Chemicals IPO GMP Grey Market Premium

As mentioned earlier, the Biopol Chemicals IPO GMP currently stands at ₹0.00 per share. Thus, the estimated listing price would be at ₹108.00. This indicates that the estimated listing gain in this IPO could be 0.00%. Explore the table for Biopol Chemicals IPO GMP updates.

GMP DATEIPO PriceGMP PriceEstimated Listing PriceEstimated Gain
6-2-2026₹108.00₹0.00₹108.000.00%
5-2-2026₹108.00₹0.00₹108.000.00%
4-2-2026₹108.00₹0.00₹108.000.00%
3-2-2026₹108.00₹0.00₹108.000.00%
2-2-2026₹108.00₹0.00₹108.000.00%
1-2-2026₹108.00₹0.00₹108.000.00%
31-01-2026₹108.00₹0.00₹108.000.00%
30-01-2026₹108.00₹0.00₹108.000.00%
29-01-2026₹108.00₹0.00₹108.000.00%
28-01-2026₹108.00₹0.00₹108.000.00%

Note: GMP details are subject to change based on market conditions and fluctuations. Check the live Biopol Chemicals IPO GMP status at Univest.

Click and Sign Up to Get Live Updates on Biopol Chemicals IPO GMP Status

Biopol Chemicals IPO Subscription Status

As of now, the Biopol Chemicals IPO has been subscribed to 0.12 times. Of these, 0.16 times are subscribed by retail investors, 0.16 times by non-institutional investors, and 0.00 times by QII (Qualified Institutional Investors).  

The healthy subscription status indicates that investors are expecting higher returns at the time of Biopol Chemicals’ IPO listing on 13th February 2026. Biopol Chemicals also has a positive outlook behind the fresh issue of 0.29 crore shares, which will raise around Rs 31.26 crores.

Note: GMP details are subject to change based on market conditions and fluctuations. Check the live Biopol Chemicals IPO Subscription status at Univest.

Click and Sign Up to Get Live Updates on Biopol Chemicals IPO Subscription Status

Biopol Chemicals IPO Details

IPO Allotment Date11th February 2026
IPO Open Date6th January 2026
IPO Close Date10th February 2026
Refund Initiation 12th February 2026
Issue Size28,94,400 shares(agg. up to ₹31 Cr)
Face Value₹10 per share
Lot Size1,200 Shares
Issue Price ₹102 to ₹108 per share
Issue TypeBookbuilding IPO
Listing AtNSE SME
Listing Date13th February 2026

Also Read: Biopol Chemicals IPO GMP & Review: Apply or Avoid?

Explanation

Biopol Chemicals IPO: Biopol Chemicals IPO Limited has declared an issue price band of ₹102 to ₹108 per share. With this IPO, the company allows retail investors to bid for at least 2 lots of 2,400 share, each worth ₹2,59,200. The face value of Biopol Chemicals IPO Limited shares is ₹10 per share. The shares of Biopol Chemicals IPO Limited will be listed on NSE and SME on its tentative listing day, 13th February 2026. Scroll down to check GMP updates and Biopol Chemicals IPO reviews. 

About Biopol Chemicals Ltd.

Biopol Chemicals Limited was established in the year 2023. Biopol Chemicals Limited manufactures and distributes speciality chemicals, including silicones, emulsifiers, biochemicals, and polyelectrolytes. The company’s product offerings include 66 products, consisting of 40 silicone products, 5 emulsifier-based products, 15 biochemical products, and 6 polyelectrolyte products. These products are used across a variety of industries, including textiles, home care, agriculture, and industrial chemicals. The company operates on the business-to-business model, catering to institutional clients rather than retail end users. The company operates the 4 establishments located in West Bengal and Gujarat, which comprise their manufacturing unit, warehouse, and corporate office in West Bengal, and the registered office located in West Bengal.

Biopol Chemicals Limited Financials

The company’s financial analysis is essential before applying for the Biopol Chemicals IPO. See the table for Biopol Chemicals Limited’s financials. 

Year Ended31st Dec 2025 (in cr.)31st March 2025 (in cr.)31st March 2024 (in cr.)
Assets48.8831.4817.56
Revenue48.9749.1517.43
Profit After Tax6.004.332.96
EBITDA8.996.534.43
Net Worth19.5413.539.20
Reserves and Surplus11.635.621.29
Total Borrowings14.927.693.58

Explanation

Biopol Chemicals Limited’s revenue increased by 181.98% from ₹17.43 crores in March 2024 to ₹49.15 crores in March 2025. Moreover, the company’s PAT increased by 46.28% from ₹2.96 crores in March 2024 to ₹4.33 crores in March 2025.

Biopol Chemicals IPO Objectives

The primary aim of the Biopol Chemicals IPO is to raise ₹31.26 crores. On the other hand, Biopol Chemicals has decided to utilise these funds in different ways.

  • To the acquisition of industrial land
  • To Repayment or prepayment, in full or in part, of borrowings availed by the Company from banks, financial institutions and non-banking financial companies 
  • To General Corporate Expenses.

Biopol Chemicals IPO Registrar

Bigshare Services Private Limited is the registrar for the Biopol Chemicals IPO, awaiting the allotment process and initiating refunds. For any queries regarding the Biopol Chemicals allotment and refund, you can contact Bigshare Services Private Limited at ipo@bigshareonline.com or at +91-22-6263 8200.

Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces! 

Biopol Chemicals IPO Review

Biopol Chemicals IPO Review

The Biopol Chemicals IPO has gained neutral ratings from industry experts, brokers, and institutional investors. Biopol Chemicals Limited’s revenue increased by 181.98% from ₹17.43 crores in March 2024 to ₹49.15 crores in March 2025. Moreover, the company’s PAT increased by 46.28% from ₹2.96 crores in March 2024 to ₹4.33 crores in March 2025.

Most analysts recommend applying for this IPO to diversify your investment portfolio. However, we’re waiting for additional ratings to get a clearer picture and will keep posting them to deliver real-time insights. Until then, you can explore the company’s technical analysis to know whether you should apply for the Biopol Chemicals IPO or not.

Key IndicatorsValue
PE Ratio (Price-to-Earnings) 19.73
EPS (Earnings Per Share)5.47
RoNW30.74%
ROCE26.32%
ROE36.32%
EBITDA Margin18.41%
Price to Book Value4.37
Market Capitalisation₹116.70 Cr

The P/E ratio of Biopol Chemicals Limited shares is 19.73, and its Earnings Per Share (EPS) stands at 5.47. Thus, the Biopol Chemicals IPO can deliver gains on its tentative listing date, 13th February 2026. 

Note: The data, as mentioned above, is taken from authentic sources and highlights pre-issue information. The PE ratio and EPS of Biopol Chemicals Limited are subject to change after the IPO. Explore the table below to get post-issue updates on these two metrics. 

IndicatorsPre-IPOPost-IPO
PE Ratio19.7314.58
EPS 5.477.41

FAQs on Biopol Chemicals IPO

What is the Biopol Chemicals IPO GMP?

Currently, on 6th February 2026, the Biopol Chemicals IPO GMP (Grey Market Premium) stands at ₹0. This indicates that the estimated listing price could be ₹108.00 per share.

What is the issue price of the Biopol Chemicals IPO?

The Biopol Chemicals IPO issue price band is set at ₹102 to ₹108 per share. Retail investors can apply for a minimum of 2 lots, each consisting of 2,400 shares, worth ₹2,59,200. Moreover, HNIs are required to bid for a minimum of 3 lots (3,600 shares) worth ₹3,88,800.

Who is the registrar of the Biopol Chemicals IPO?

Bigshare Services Private Limited is the registrar for the Biopol Chemicals IPO, awaiting the allotment process and initiating refunds. For any queries regarding the Biopol Chemicals allotment and refund, you can contact Bigshare Services Private Limited at ipo@bigshareonline.com or at +91-22-6263 8200.

Disclaimer: The above information is compiled from authentic sources and is just for informational purposes. To have detailed information about the Biopol Chemicals IPO, download the Biopol Chemicals IPO RHP and Biopol Chemicals IPO DRHP. Conduct your research before investing in IPOs to avoid significant losses. You can also consult your financial advisor.

Recent Articles

Grover Jewells IPO Day 2: Subscription at 1.36x, GMP Rises 2.84% | Live Updates

Biopol Chemicals IPO Day 2: Subscription at 1.26x, GMP Jumps 12.50% | Live Updates

Accretion Nutraveda IPO Listing at 48% Premium at ₹191 Per Share

Msafe Equipments IPO Listing at 22.93% Premium at ₹123 Per Share

Kanishk Aluminium India IPO Listing at 20% Premium at ₹58.40 Per Share

Aye Finance IPO Review 2026: GMP Rises 0.28%, Key Investor Insights

Fractal Analytics IPO Review 2026: GMP Rises 9.33%, Key Investor Insights